Health leaders and caregivers are focused on evidence-based data to drive care delivery and practice. Ensuring the health system is functioning effectively and efficiently and that patient outcomes are reaching expected targets are topics that permeate conversations at the local, provincial, and national levels. However, as many leaders have come to understand in recent years, healthcare data collection and producing meaningful, high-quality metrics is a complex set of tasks, requiring its own level of attention and dedicated resources. In the healthcare data realm, there are opportunities to learn from experience. One of these opportunities is the population-based cancer registry, which is one of the oldest examples of standardized data collection in the Canadian health system.
Introduction
Health leaders and caregivers are focused on evidence-based data to drive care delivery and practice. Ensuring the health system is functioning effectively and efficiently and that patient outcomes are reaching expected targets are topics that permeate conversations at the local, provincial, and national levels. However, as many leaders have come to understand in recent years, healthcare data collection and producing meaningful, high-quality metrics is a complex set of tasks, requiring its own level of attention and dedicated resources. In the healthcare data realm, there are opportunities to learn from experience. One of these opportunities is the population-based Cancer Registry (CR), which is one of the oldest examples of standardized data collection in the Canadian health system.
Canadian cancer registries-An overview
Often hailed as an innovator in developing healthcare infrastructure, the province of Saskatchewan began registering cancer cases in 1932 as part of its coordinated approach for persons diagnosed with and receiving treatment for cancer.
1(para [5] [6] [7] [8] The remaining provinces and territories all established population-based cancer registries at various points throughout the 1960s and 1970s, and by 1969, several of the provinces began contributing to a National Registry Database (NCIRS) operated by Statistics Canada (SC). 2 Moving to a national system allowed for more collaboration on data standard development and an increased focus on data quality and use. In 1992, the original NCIRS evolved to become the Canadian Cancer Registry (CCR), still under SC, with oversight from the Canadian Council of Cancer Registries (CCCR). The Council has representation from each Provincial/Territorial Cancer Registry (PTCR) and SC and provides direction on national data collection standards and quality management (SC). 3, 4 There is no "one size" fits all in the CR domain. Registries vary on many parameters, including case ascertainment and consolidation methods, range of cancer cases collected, and scope of data collected. 5, 6 At its core, the CR is responsible for identifying all newly diagnosed cancer cases and collecting a standardized set of data including diagnosis, staging, treatment, and outcomes. 5 In Canada, the PTCRs and the CCR support a wide range of cancer control requirements including disease and treatment surveillance, research, system planning, and program evaluation. Establishing a clear purpose for a registry is essential for determining the parameters that will apply to its operations. 6 In Canada, the majority of PTCRs operate as a central registry and collect data for an entire jurisdiction. At present, Canadian PTCRs are located within each provincial health system, generally under a government health department, a provincial cancer agency, or other administrative health structure 4 In many jurisdictions (eg, British Columbia [BC], Nova Scotia [NS]), cancer is a reportable disease through legislative authority. 7 Data collection in most Canadian and US CRs is carried out by trained health information professionals (cancer registrars), who are knowledgeable in the myriad of CR standards such as diagnosis and histology coding systems, multiple primary rules, and stage data collection. The need for standardization cannot be underestimated in the CR as it provides the backbone for ensuring data can be used and interpreted consistently across time and place. 8 In 1995, Canada collaborated with its US central registry partners to form an entity known as the North American Association of Central Cancer Registries (NAACCR). This body brings together all major CR standard setters (National Cancer Institute, US Centers for Disease Control, CCCR, and the American Joint Committee on Cancer [AJCC]) with other key stakeholders to promote standardized CR operations, data collection standards, and education. 9 This organization contributes to improved CR quality that supports the overall utility of the data for a range of purposes including comparability of measures at an international level. Those working in the cancer field in this country are accustomed to having easily accessible data on the population impact of cancer. Counts of cases by province and territory, age-standardized incidence rates, relative survival data, and trends over time are readily accessible. Canadian Cancer Statistics is an annual publication that utilizes the valuable data collected at the PTCR level through a regular analysis of the CCR database. 10 Similar analyses are routinely prepared at the PTCR level and provide even greater insight into the functioning of the cancer system in this country.
Ensuring the CR remains relevant
Cancer registration as a process with its attendant infrastructure and oversight is well entrenched in the cancer control system within Canada and worldwide. 6 Despite its history and strong foundations, the CR is not immune to the rapid pace of change within the cancer control continuum and the healthcare system at large. To remain relevant for the future, the CR has to demonstrate greater flexibility and more rapid adaptation to changing times and expectations while maintaining highquality data. In addition, perhaps because of its long history, CR groups have not always considered the need to "market" their registry data and help other stakeholders understand its value and potential.
In recent years, CRs have been challenged on several key issues such as timeliness of data availability, changing cancer data standards and demands for increased data collection, and third-party access to data. These issues are frequently highlighted as evidence that the CR is unable to meet cancer program needs. In reality, these issues are complex and they appear to be consistent with challenges facing information management across the healthcare system. Overlying these issues is the increased burden of cancer in Canada which is expected to continue well into the future. Woods et al. 11 predict the number of new cancer diagnoses in BC will grow by 57% between 2012 and 2030, largely related to population aging and growth. Change of this magnitude in case volume will place a significant impact on CR resources and infrastructure. The following sections of this article will more closely examine some of the challenges currently facing CRs and consider how they can be reconciled in the future.
Improving timeliness and maintaining quality
Registries by their nature prefer stability and are focused on producing a high-quality, complete data set. Stable data definitions and collection practices allow for cleaner data and an improved ability to identify changes in statistical patterns and trends that may be related to external factors. 6, 12 In addition, the growing number of cancer cases only serves to increase workload year over year. In the CR, the most recent year of complete data is often 2 to 3 years old. Registries prefer to wait until every case has been counted, and fulsome quality assurance cycles are complete before data are analyzed and made available to stakeholders. 6 In a world that relies increasingly on electronic media and instant messaging, as well as one that demands greater accountability from the healthcare system to monitor current practice, this type of lag is no longer acceptable. Registries recognize the time dilemma and are collectively working to reduce the gap. It may never be realistic or appropriate to have data in real time, as a cancer diagnosis itself does not occur as a result of a single event but often reflects the outcomes of a series of investigations and episodes of care. However, it may be possible to more rapidly assemble cancer diagnostic and treatment data in the future as electronic data collection expands in the direct patient care setting. Standardized synoptic reporting of cancer events (eg, operative reports, radiological examinations, and pathology specimen review) that can be transmitted electronically to the CR and directly populated into data fields will save time. 6 A key to ensuring that this process will work for the CR is to have the registry and health surveillance perspective represented in the clinical environments where relevant cancer data collection decisions are made and at the point when information system infrastructure is created. Improving methods to electronically consolidate conflicting cancer case information from multiple electronic sources will also assist in data processing. 6, 13 Registries have often worked on an all or none premise. All the possible data are collected on every case. In an environment with limited resources, different approaches may be necessary. Can a core set of data be collected on all cases with additional expanded data collected for only defined time periods or for a representative sample of cases? Cancer registry professionals are exploring and working to validate these types of solutions through forums such as NAACCR and can provide advice and guidance for future CR operations.
Timeliness is just one aspect of collecting quality data that will be used to create useful information. Validity, accuracy, coherence, and accessibility are other equally important considerations in registry operations.
14 A comprehensive CR program must achieve a balance between quality data and the need to do more in a shorter time frame.
Changing data standards and collection requirements
Technology has increased our capacity to "see things differently" and assess patient status using new terminology and greater specificity. Communication of advances is so rapid that clinicians are often incorporating new data and terminology into their paper-based and electronic reporting before it is standardized or even known to other downstream users such as the CR.
Increasing availability of electronic data systems is seen as the panacea to collecting as much data as possible and having it available for future use. Experience from the CR would suggest that significant thought be given to the rationale for collecting even a single additional variable before it is added as a data requirement. Many healthcare data systems are "littered" with data variables that have been collected historically, without any evidence of use. The work associated with data collection, even when automated does have an impact on business processes, information technology system operations, documentation, and overall resource use. It is essential to develop detailed standards and definitions including the relevance and utility for each new data element proposed for collection.
In the cancer control arena, there is continuous pressure to expand data collection to support changing needs related to surveillance, cancer program operations, and research. An example of a new standard with significant data collection impacts at the CR level is the upcoming 2018 introduction of the AJCC TNM 8 th Edition for Staging (2017), 15 which reflects current cancer staging expectations from across the broad clinical oncology community. The version includes important updates to prognostic indicators and finer gradations of stage groupings for many disease sites. Cancer registry information systems will require major upgrades to accommodate the new data requirements with ripple effects on areas such as staff training, automated edit processes, and reporting parameters.
Ensuring that CR and clinical data requirements are in alignment is an important consideration. Working closely with cancer care providers on defining data requirements and seeking opportunities to share data available in point-of-care Electronic Medical Records (EMRs) allows the CR to leverage existing infrastructure and avoid the need for manual data collection. This working relationship also improves the awareness of both groups regarding the challenges in collecting high-quality data. A recent successful project involving NS, BC, and PEI piloted the linkage and transmission of a standardized extract of radiation treatment data from a provincial radiotherapy EMR and its transmission and integration with the provincial CR information system in each jurisdiction. 16 In Canada, the advent of the Canadian Partnership Against Cancer has raised renewed interest in the CR as a tool for national-level cancer system performance measurement. 17 At the end of the day, the CR remains the one standardized provincial/territorial level data system where the complete count or denominator of all diagnosed cancer cases resides, where well-defined time elements (eg, date of diagnosis) and linkage identifiers are recorded. The CR can therefore be used to "link" with other key data holdings such as the discharge abstract database managed by the Canadian Institute for Health Information 18 to examine specific questions or indicators related to system performance such as treatment guideline concordance. Most clinical systems reflect experience and outcomes for patients who receive a specific treatment(s) but typically cannot be used independently to examine uptake or adherence for all diagnosed (incident) cases. Cancer registry data sets also include routine death status updates, providing a critical outcome variable for assessing cancer interventions. Data linkage collaborations are an important opportunity for the CR to demonstrate value to cancer control partners.
Increasing data access and availability
In Canada as in many countries, there is a growing focus on the privacy and security of health information. In the last 15 years, most PTCRs have been affected by the implementation of specific health information legislation that lays out clear processes and parameters for when and how CR and other data can be used and disclosed. 7 New application processes and sharing agreements are often required to permit data access to non-registry staff and researchers and these steps can be perceived as a barrier. Ensuring that clear documentation is prepared and available to potential end users detailing any required processes and expected timelines can be helpful in reducing negativity associated with requesting CR data. Additional descriptive documentation on the scope of data in the CR and what is available for release can also indicate a willingness to work with other stakeholders.
Summary
The CR example illustrates the challenges and opportunities in maintaining a high-quality healthcare data system. Long-term experience has taught CR leadership important lessons:
Cancer registries benefit from a comprehensive and coordinated approach to operations, quality, and standards. Clearly defined data requirements are essential to maintaining the utility of CR data. Increasing awareness of and accessibility to CR data is paramount to ensure relevance to the cancer control community.
Utilizing new technologies, systems, and partnerships in response to changing demands for timely, more comprehensive and accessible data is allowing CRs to remain relevant in their core business of providing a standardized set of data (diagnosis, staging, treatment, and outcomes) on all newly diagnosed cancer cases (see Table 1 ).
